This is a Validated Antibody Database (VAD) review about cow ATM, based on 21 published articles (read how Labome selects the articles), using ATM antibody in all methods. It is aimed to help Labome visitors find the most suited ATM antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
ATM synonym: serine-protein kinase ATM; ataxia telangiectasia mutated

Cell Signaling Technology
rabbit monoclonal (D6H9)
  • other; human; loading ...; fig 4c
Cell Signaling Technology ATM antibody (Cell Signaling, 5883) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
rabbit monoclonal (D6H9)
  • western blot; human; fig s1c
Cell Signaling Technology ATM antibody (Cell Signaling, 5883) was used in western blot on human samples (fig s1c). Cell (2018) ncbi
rabbit monoclonal (D6H9)
  • immunocytochemistry; human; loading ...; fig 2b
  • western blot; human; loading ...; fig 2b
In order to investigate the role of ILF2 in RNA splicing and DNA damage response in multiple myeloma, Cell Signaling Technology ATM antibody (Cell Signaling, 5883) was used in immunocytochemistry on human samples (fig 2b) and in western blot on human samples (fig 2b). Cancer Cell (2017) ncbi
rabbit monoclonal (D6H9)
  • western blot; human; loading ...; fig 5a
In order to identify factors that contribute to adenoviral transduction stimulation of IL-33 in endothelial cells, Cell Signaling Technology ATM antibody (Cell Signaling, D6H9) was used in western blot on human samples (fig 5a). J Immunol (2017) ncbi
rabbit monoclonal (D6H9)
  • flow cytometry; human; fig s2e
Cell Signaling Technology ATM antibody (Cell Signaling, D6H9) was used in flow cytometry on human samples (fig s2e). J Immunol (2016) ncbi
rabbit monoclonal (D6H9)
  • western blot; human; fig s2a
In order to propose that ABHD5 has a PNPLA2-independent function in regulating autophagy and tumorigenesis, Cell Signaling Technology ATM antibody (Cell Signaling, 5883) was used in western blot on human samples (fig s2a). Autophagy (2016) ncbi
rabbit monoclonal (D6H9)
  • western blot; human; fig 4
Cell Signaling Technology ATM antibody (Signaling Technology, 5883) was used in western blot on human samples (fig 4). J Cell Mol Med (2016) ncbi
rabbit monoclonal (D6H9)
  • western blot; human; 1:500; loading ...; fig 4a
Cell Signaling Technology ATM antibody (Cell Signaling, 5883) was used in western blot on human samples at 1:500 (fig 4a). Oncotarget (2016) ncbi
rabbit monoclonal (D6H9)
  • western blot; mouse; fig 3
Cell Signaling Technology ATM antibody (Cell Signaling Technology, 5883) was used in western blot on mouse samples (fig 3). Sci Rep (2016) ncbi
rabbit monoclonal (D6H9)
  • western blot; human; fig 7
Cell Signaling Technology ATM antibody (Cell Signaling Technology, D6H9) was used in western blot on human samples (fig 7). Cell Cycle (2016) ncbi
rabbit monoclonal (D6H9)
  • western blot; human; fig 4d
Cell Signaling Technology ATM antibody (Cell Signaling, 5883) was used in western blot on human samples (fig 4d). J Biol Chem (2016) ncbi
rabbit monoclonal (D6H9)
  • western blot; human; fig 3
In order to study ATM-dependent responses to double-strand DNA breaks, Cell Signaling Technology ATM antibody (Cell Signaling Technology, D6H9) was used in western blot on human samples (fig 3). Sci Rep (2016) ncbi
rabbit monoclonal (D6H9)
  • western blot; human; loading ...; fig 5c
In order to study the effect of galiellalactone in regards to cell cycle arrest and apoptosis via ATM/ATR pathway in prostate cancer cells, Cell Signaling Technology ATM antibody (Cell Signaling, 5883) was used in western blot on human samples (fig 5c). Oncotarget (2016) ncbi
rabbit monoclonal (D6H9)
  • western blot; human; fig 1
Cell Signaling Technology ATM antibody (Cell signaling, 5883) was used in western blot on human samples (fig 1). Biochem Biophys Res Commun (2015) ncbi
rabbit monoclonal (D6H9)
  • western blot; human; fig 2
Cell Signaling Technology ATM antibody (Cell Signaling, 5883P) was used in western blot on human samples (fig 2). Aging (Albany NY) (2015) ncbi
rabbit monoclonal (D6H9)
  • western blot; human; 1:1000; loading ...; fig 4c, d
Cell Signaling Technology ATM antibody (Cell Signaling, 5883) was used in western blot on human samples at 1:1000 (fig 4c, d). Oncotarget (2015) ncbi
rabbit monoclonal (D6H9)
  • immunocytochemistry; human; fig 7
  • western blot; human; fig 7
Cell Signaling Technology ATM antibody (Cell Signaling Tech, 5883) was used in immunocytochemistry on human samples (fig 7) and in western blot on human samples (fig 7). Cell Death Differ (2015) ncbi
rabbit monoclonal (D6H9)
  • western blot; human; fig S11
Cell Signaling Technology ATM antibody (Cell Signaling, 5883) was used in western blot on human samples (fig S11). Nat Commun (2015) ncbi
rabbit monoclonal (D6H9)
  • western blot; human; 1:1000; fig 7d
In order to show that the zinc finger E-box binding homeobox 1 regulates radiosensitivity and the DNA damage response in breast cancer cells, Cell Signaling Technology ATM antibody (Cell Signaling Technology,, 5883) was used in western blot on human samples at 1:1000 (fig 7d). Nat Cell Biol (2014) ncbi
rabbit monoclonal (D6H9)
  • western blot; human
In order to explore DNA repair responses in human pluripotent stem cells, Cell Signaling Technology ATM antibody (Cell signaling, 5883) was used in western blot on human samples . J Biol Chem (2014) ncbi
rabbit monoclonal (D6H9)
  • immunocytochemistry; human; 1:250
Cell Signaling Technology ATM antibody (Cell Signaling, 5883) was used in immunocytochemistry on human samples at 1:250. PLoS ONE (2014) ncbi
Articles Reviewed
  1. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  2. Mohamed T, Ang Y, Radzinsky E, Zhou P, Huang Y, Elfenbein A, et al. Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration. Cell. 2018;173:104-116.e12 pubmed publisher
  3. Marchesini M, Ogoti Y, Fiorini E, Aktaş Samur A, Nezi L, D Anca M, et al. ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma. Cancer Cell. 2017;32:88-100.e6 pubmed publisher
  4. Stav Noraas T, Edelmann R, Poulsen L, Sundnes O, Phung D, Küchler A, et al. Endothelial IL-33 Expression Is Augmented by Adenoviral Activation of the DNA Damage Machinery. J Immunol. 2017;198:3318-3325 pubmed publisher
  5. Muller Durovic B, Lanna A, Covre L, Mills R, Henson S, Akbar A. Killer Cell Lectin-like Receptor G1 Inhibits NK Cell Function through Activation of Adenosine 5'-Monophosphate-Activated Protein Kinase. J Immunol. 2016;197:2891-2899 pubmed publisher
  6. Peng Y, Miao H, Wu S, Yang W, Zhang Y, Xie G, et al. ABHD5 interacts with BECN1 to regulate autophagy and tumorigenesis of colon cancer independent of PNPLA2. Autophagy. 2016;12:2167-2182 pubmed
  7. Ah Koon L, Lesage D, Lemadre E, Souissi I, Fagard R, Varin Blank N, et al. Cellular response to alkylating agent MNNG is impaired in STAT1-deficients cells. J Cell Mol Med. 2016;20:1956-65 pubmed publisher
  8. Heckler M, Zeleke T, Divekar S, Fernandez A, Tiek D, Woodrick J, et al. Antimitotic activity of DY131 and the estrogen-related receptor beta 2 (ERRβ2) splice variant in breast cancer. Oncotarget. 2016;7:47201-47220 pubmed publisher
  9. He D, Xiang J, Li B, Liu H. The dynamic behavior of Ect2 in response to DNA damage. Sci Rep. 2016;6:24504 pubmed publisher
  10. Köhler C, Koalick D, Fabricius A, Parplys A, Borgmann K, Pospiech H, et al. Cdc45 is limiting for replication initiation in humans. Cell Cycle. 2016;15:974-85 pubmed publisher
  11. Chavoshi S, Egorova O, Lacdao I, Farhadi S, Sheng Y, Saridakis V. Identification of Kaposi Sarcoma Herpesvirus (KSHV) vIRF1 Protein as a Novel Interaction Partner of Human Deubiquitinase USP7. J Biol Chem. 2016;291:6281-91 pubmed publisher
  12. Kralovicova J, Knut M, Cross N, Vorechovsky I. Exon-centric regulation of ATM expression is population-dependent and amenable to antisense modification by pseudoexon targeting. Sci Rep. 2016;6:18741 pubmed publisher
  13. García V, Lara Chica M, Cantarero I, Sterner O, Calzado M, Muñoz E. Galiellalactone induces cell cycle arrest and apoptosis through the ATM/ATR pathway in prostate cancer cells. Oncotarget. 2016;7:4490-506 pubmed publisher
  14. Murata Y, Uehara Y, Hosoi Y. Activation of mTORC1 under nutrient starvation conditions increases cellular radiosensitivity in human liver cancer cell lines, HepG2 and HuH6. Biochem Biophys Res Commun. 2015;468:684-90 pubmed publisher
  15. Waye S, Naeem A, Choudhry M, Parasido E, Tricoli L, Sivakumar A, et al. The p53 tumor suppressor protein protects against chemotherapeutic stress and apoptosis in human medulloblastoma cells. Aging (Albany NY). 2015;7:854-68 pubmed
  16. Xiong Y, Su H, Lv P, Ma Y, Wang S, Miao H, et al. A newly identified berberine derivative induces cancer cell senescence by stabilizing endogenous G-quadruplexes and sparking a DNA damage response at the telomere region. Oncotarget. 2015;6:35625-35 pubmed publisher
  17. Warren D, Tajsic T, Porter L, Minaisah R, Cobb A, Jacob A, et al. Nesprin-2-dependent ERK1/2 compartmentalisation regulates the DNA damage response in vascular smooth muscle cell ageing. Cell Death Differ. 2015;22:1540-50 pubmed publisher
  18. Wang L, Liu R, Ye P, Wong C, Chen G, Zhou P, et al. Intracellular CD24 disrupts the ARF-NPM interaction and enables mutational and viral oncogene-mediated p53 inactivation. Nat Commun. 2015;6:5909 pubmed publisher
  19. Zhang P, Wei Y, Wang L, Debeb B, Yuan Y, Zhang J, et al. ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1. Nat Cell Biol. 2014;16:864-75 pubmed publisher
  20. Lin B, Gupta D, Heinen C. Human pluripotent stem cells have a novel mismatch repair-dependent damage response. J Biol Chem. 2014;289:24314-24 pubmed publisher
  21. Stimpson K, Sullivan L, Kuo M, Sullivan B. Nucleolar organization, ribosomal DNA array stability, and acrocentric chromosome integrity are linked to telomere function. PLoS ONE. 2014;9:e92432 pubmed publisher